Cargando…

Association of Optimal Blood Pressure With Critical Cardiorenal Events and Mortality in High-Risk and Low-Risk Patients Treated With Antihypertension Medications

IMPORTANCE: There are few studies comparing the optimal level of treated blood pressure (BP) between high- and low-risk patients. OBJECTIVE: To examine whether optimally treated BP is different according to risk status. DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study using data from...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jung, Hae Hyuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714012/ https://www.ncbi.nlm.nih.gov/pubmed/31441935 http://dx.doi.org/10.1001/jamanetworkopen.2019.9307

Ejemplares similares

Use of Antihypertensives, Blood Pressure, and Estimated Risk of Dementia in Late Life: An Individual Participant Data Meta-Analysis
por: Lennon, Matthew J., et al.
Publicado: (2023)

Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence
por: Schechter, Meir, et al.
Publicado: (2021)

Effects of intensive blood pressure control on mortality and cardiorenal function in chronic kidney disease patients
por: Zhang, Yong, et al.
Publicado: (2021)

Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China
por: Lu, Qi, et al.
Publicado: (2022)

Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg
por: Li, Jingen, et al.
Publicado: (2021)

Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes
por: Georgakis, Marios K., et al.
Publicado: (2020)

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial
por: Wijkman, Magnus O., et al.
Publicado: (2020)

Cardiorenal Systems Modeling: Left Ventricular Hypertrophy and Differential Effects of Antihypertensive Therapies on Hypertrophy Regression
por: Hallow, K. Melissa, et al.
Publicado: (2021)

Risk factors and electrocardiogram characteristics for mortality in critical inpatients with COVID‐19
por: Li, Lingzhi, et al.
Publicado: (2020)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Ambulatory blood-pressure monitoring, antihypertensive therapy and the risk of fall injuries in elderly hypertensive patients
por: Jonas, Michael, et al.
Publicado: (2018)

Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients
por: Chen, Hung-Yuan, et al.
Publicado: (2014)

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

Benefits and risks of antihypertensive medication in adults with different systolic blood pressure: A meta-analysis from the perspective of the number needed to treat
por: Mao, Yucheng, et al.
Publicado: (2022)

Association of Blood Pressure With Cause-Specific Mortality in Mexican Adults
por: Tapia-Conyer, Roberto, et al.
Publicado: (2020)

The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study
por: van Herpt, Thijs T. W., et al.
Publicado: (2016)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Sharif, Shahnam, et al.
Publicado: (2021)

The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes
por: Hägg-Holmberg, Stefanie, et al.
Publicado: (2019)

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
por: Ruilope, Luis M., et al.
Publicado: (2022)

Immediate Prescription of Oral Antihypertensive Agents in Hypertensive Urgency Patients and the Risk of Revisits with Elevated Blood Pressure
por: Sricharoen, Pungkava, et al.
Publicado: (2020)

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2021)

Blood Pressure Variability as a Risk Factor for Cardiovascular Disease: Which Antihypertensive Agents Are More Effective?
por: de la Sierra, Alejandro
Publicado: (2023)

Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications: A Systematic Review and Network Meta-analysis
por: Wei, Jingkai, et al.
Publicado: (2020)

Corrigendum: Benefits and risks of antihypertensive medication in adults with different systolic blood pressure: A meta-analysis from the perspective of the number needed to treat
por: Mao, Yucheng, et al.
Publicado: (2022)

Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis
por: Mahal, Brandon A., et al.
Publicado: (2023)

Association of Longitudinal Patterns of Habitual Sleep Duration With Risk of Cardiovascular Events and All-Cause Mortality
por: Wang, Yun-He, et al.
Publicado: (2020)

Fifty Shades of Central Venous Pressure in the Cardiorenal Syndrome
por: Redant, Sebastien, et al.
Publicado: (2020)

Year-by-Year Blood Pressure Variability From Midlife to Death and Lifetime Dementia Risk
por: den Brok, Melina G. H. E., et al.
Publicado: (2023)

Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort study
por: Kim, Hack-Lyoung, et al.
Publicado: (2020)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2020)

Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents
por: Lengel, Dave, et al.
Publicado: (2015)

Circulating microparticles and central blood pressure according to antihypertensive strategy
por: Massunaga, Nayara D., et al.
Publicado: (2019)

Association of Optimism With Cardiovascular Events and All-Cause Mortality: A Systematic Review and Meta-analysis
por: Rozanski, Alan, et al.
Publicado: (2019)

Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management
por: Zamorano, José, et al.
Publicado: (2011)

Exaggerated blood pressure response during the exercise treadmill test as a risk factor for hypertension
por: Lima, S.G., et al.
Publicado: (2013)

Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial
por: Scarpa, Joseph, et al.
Publicado: (2019)

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
por: Giugliano, Dario, et al.
Publicado: (2021)

Fructose: Toxic effect on cardiorenal risk factors and redox state
por: Francisqueti, Fabiane V, et al.
Publicado: (2016)

Microalbuminuria and cardiorenal risk: old and new evidence in different populations
por: Márquez, Diego Francisco, et al.
Publicado: (2019)

Development and Validation of a Risk Stratification Model Using Disease Severity Hierarchy for Mortality or Major Cardiovascular Event
por: Ngufor, Che, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5vm2v4pmrj8ccks8bpb8sgb2gm